ADHDIOM-ADHDNCT05520996
Impact of Ostracism on Prospective Memory in ADHD Children With or Without Emotional Dysregulation
An observational study of ADHD, run by University Hospital, Rouen at 1 site in France.
Trial summary
Assess the effect of exposure to a situation of social exclusion or ostracism on the prospective memory of children with ADHD Read more about this study
- Who is it for?
- Ages 8 to 12 years
- Conditions the study is for
- ADHD
- What is being tested?
- Cyberball
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 24 participants
- Where
- 1 siteFrance
- Study dates
- 15 Dec 2021to 21 Jun 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 12 years
- All sexes
- No healthy volunteers
- Child
Study population: Child with attention deficit disorder with or without hyperactivity
Who may be able to join
- Child with attention deficit disorder with or without hyperactivity (ADHD) according to the following criteria: score greater than 27 on the ADHD-RS scale or score greater than 65 on the Conners scale, and after clinical staff discussion
- Social security
- non opposition of parents and children to the study
Who cannot join
- Subject presenting elements in favor of a depressive disorder according to a clinical evaluation and on an evaluation by the CBCL scale
- Minor and/or parents who do not understand French
- Person under legal protection, adult guardianship or curatorship.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Impact of Ostracism on Prospective Memory in ADHD Children With or Without Emotional Dysregulation/ Impact de l'Ostracisme Sur la mémoire Prospective Chez Des Enfants Atteint de TDA/H Avec ou Sans dysrégulation émotionnelle.
Assess the effect of exposure to a situation of social exclusion or ostracism on the prospective memory of children with ADHD
- Conditions
- ADHD
- Being tested
- Cyberball
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CyberballBehavioural
Social exclusion or ostracism can be measured by the Cyberball 5 task. The principle of Cyberball is based on the creation of a situation of exclusion through a computerized task. During this task, the participant passes a ball to 2 other players controlled by Artificial Intelligence (AI). The ball-passing method of AI-controlled players is determined in advance in the computer program code. A series of ball passing is carried out with initially an equal passing between the three participants and then an exclusive passing between the players controlled by an artificial intelligence
| Study group | Role | What they receive |
|---|---|---|
| one arm study | Memory test performed before and after cyberball task Receives: Behavioral: Cyberball |
What is being measured
The primary outcome is the main question the study is designed to answer.
difference between prospective memory tests performed before and after cyberball task
Promacy test is a Memory test performed before and after Cyberball task
Measured: At inlcusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Aug 2022
- Study start15 Dec 2021
- Primary completion21 Jun 2022
- Study completion21 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ADHDStudies of the same condition, open and under way.
- More trials run by University Hospital, RouenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Rouen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05520996
- Sponsor's protocol ID
- 2021/0224/OB
- Acronym
- IOM-ADHD
- Status last verified
- Apr 2026
- First submitted
- 14 Mar 2022
- Last updated
- 4 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Ostracism on Prospective Memory in ADHD Children With or Without Emotional Dysregulation/ Impact de l'Ostracisme Sur la mémoire Prospective Chez Des Enfants Atteint de TDA/H Avec ou Sans dysrégulation émotionnelle.
- ClinicalTrials.gov ID
- NCT05520996
- Acronym / sponsor ID
- IOM-ADHD / 2021/0224/OB
- Conditions
- ADHD
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 24 participants (actual)
- Lead sponsor
- University Hospital, RouenUniversity, hospital or other
- Study start
- 15 Dec 2021 (actual)
- Primary completion
- 21 Jun 2022 (actual)
- Study completion
- 21 Jun 2022 (actual)
- First posted
- 30 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Assess the effect of exposure to a situation of social exclusion or ostracism on the prospective memory of children with ADHD
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| one arm study | – | Behavioral: CyberballMemory test performed before and after cyberball task |
Who may qualify
- Ages
- 8 to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Child with attention deficit disorder with or without hyperactivity
Key inclusion criteria (3 listed)
- Child with attention deficit disorder with or without hyperactivity (ADHD) according to the following criteria: score greater than 27 on the ADHD-RS scale or score greater than 65 on the Conners scale, and after clinical staff discussion
- Social security
- non opposition of parents and children to the study
Key exclusion criteria (3 listed)
- Subject presenting elements in favor of a depressive disorder according to a clinical evaluation and on an evaluation by the CBCL scale
- Minor and/or parents who do not understand French
- Person under legal protection, adult guardianship or curatorship.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CyberballSocial exclusion or ostracism can be measured by the Cyberball 5 task. The principle of Cyberball is based on the creation of a situation of exclusion through a computerized task. During this task, the participant passes a ball to 2 other players controlled by Artificial Intelligence (AI). The ball-passing method of AI-controlled players is determined in advance in the computer program code. A series of ball passing is carried out with initially an equal passing between the three participants and then an exclusive passing between the players controlled by an artificial intelligence | Behavioural | one arm study |
Primary outcome
difference between prospective memory tests performed before and after cyberball task
Time frame: At inlcusion
Promacy test is a Memory test performed before and after Cyberball task
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 May 2026.
- Individual participant dataSharing planned: No
Related trials for ADHD
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
Recruiting
Micronutrient Supplementation and Chronotherapy in Children With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
RecruitingPhase 3
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of ADHD, run by University Hospital, Rouen at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
difference between prospective memory tests performed before and after cyberball task (time frame: At inlcusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.